Featured news, clinical trials, MSU updates and more.
, , Featured, Inclusion Body Myositis (IBM)
If you have been diagnosed with inclusion body myositis you may be wondering how you can track your disease...
, , Featured, Inclusion Body Myositis (IBM), News
New IBM Specialty Clinic at Washington University in St Louis MO to be headed up by Dr. Conrad “Chris”...
, , Featured, Myositis
The first step when approaching a patient with muscle weakness - Differential diagnosis of idiopathic inflammatory myopathies in adults....
MSU has come a long way since the beginning in 2010 with our first Facebook support group and subsequent...
, , Dermatomyositis, Featured, News
Corbus launches DETERMINE, a Phase 3 trial of lenabasum for the treatment of dermatomyositis. Double-blind, randomized, placebo-controlled, efficacy and...
, , Dermatomyositis, Featured, News
The research found that DM patients with the anti-transcriptional intermediary factor 1 (anti-TIF1) antibody were more than three times...
The authors propose that a new classification system for Idiopathic Inflammatory Myopathies (IIM) based on phenotypic (observable characteristics), biologic...
MSU is just getting started. You see, as long as there are still people dying from the various myositis...
, , Featured, News
Clinical trials and studies require patient groups in clearly defined categories, but the multiple diagnostic and classification criteria used...
, , Featured, Inclusion Body Myositis (IBM)
The purpose of this article is to describe advancements in the diagnosis of Inclusion Body Myositis (IBM) and therapy...
One of our goals is to provide inclusion body myositis patients with access to research. MSU is excited to...
, , Featured, News
In this study, the researchers set out to determine if there was a distinction between the type of autoantibodies...
, , Featured, Necrotizing Autoimmune Myopathy
Statins are drugs that lower cholesterol. There have been reports indicating that statin use may be associated with idiopathic...
Corbus Pharmaceuticals announced today that they will proceed with a Phase 3 clinical trial to evaluate the efficacy and...
Explaining myositis (Idiopathic Inflammatory Myopathy) and how it affects our lives is difficult. There isn’t a simple, clear-cut answer...
Inclusion Body Myositis Functional Rating Scale (IBMFRS) January 14, 2019
Inclusion Body Myositis Specialty Clinic at Washington University, St. Louis January 10, 2019
The first step when approaching a patient with muscle weakness – Differential diagnosis of idiopathic inflammatory myopathies in adults January 9, 2019
MSU works to improve the lives and empower those fighting Myositis through education, support, awareness, advocacy, and access to research. We are the leading nonprofit for myositis support for patients and caregivers.
As an organization in the rare community, we recognize that by collaborating with others we can do more than acting alone. We have committed to THRIVE to empower others in the rare community. Join us at thriveforrare.org
Send this to a friend
